Delivery Order SPE2DB22D1202-SPE2DB25FVKE7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,944.08 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count packages) with a completion date of August 11, 2025. This competitively awarded, non-set-aside contract operates under a firm fixed price arrangement and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,914.75 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 100 mg, a controlled-release pain management pharmaceutical. This contract type delivery order carries firm fixed pricing and was competitively awarded with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 17, 2025. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,899.74 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta ER 50 mg tablets (60-count) under a firm fixed-price contract valued at $1,194.33. The award, issued on August 18, 2025, represents a non-set-aside competitive award with an ultimate completion date of August 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Nucynta ER 200 mg tablets (60-count units) valued at $6,544.05 under a firm fixed-price contract type. The award, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its...
- The Defense Logistics Agency awarded a delivery order valued at $2,729.17 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count units) on June 20, 2025, with an ultimate completion date of June 23, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) valued at $2,944.08 under a firm fixed-price contract. This delivery order represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling and extends through December 2026. The award was competitively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Nucynta ER 100 mg tablets (60-count) with a ceiling value of $1,400.62. This competitive, non-set-aside delivery order represents a firm fixed price contract with an ultimate completion date of August 27, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count units) under a firm fixed-price contract valued at $1,472.04. The award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-competitive delivery order executed without set-aside provisions. This transaction falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Nucynta ER 150 mg tablets (60-count units) with a contract ceiling value of $4,749.30. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open procurement process. The order is scheduled for ultimate completion on August 21, 2025, and will be fulfilled from AmerisourceBergen's corporate office...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVKE7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count units) under a firm fixed-price contract valued at $1,472.04. This non-set-aside award, effective September 3, 2025 with an ultimate completion date of September 4, 2025, represents a single delivery order for pain management pharmaceutical products. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order operates as a child contract under AmerisourceBergen's substantially larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, vaccines, medical devices, and related healthcare commodities to support military healthcare programs worldwide. Through this delivery order mechanism, AmerisourceBergen continues its role as a critical pharmaceutical vendor for federal medical procurement, serving defense and veteran healthcare systems with specialized medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/3/25 |